Silu Liu, Qingqing Pan, Hongzhe Zhang, Linyi Peng, Wen Zhang, YunLu Feng, Dong Wu, Yaping Luo
{"title":"Differences in Fibroinflammatory Activity Shown on 68Ga-FAPI-04 and 18F-FDG PET/CT in the Two Subtypes of IgG4-Related Disease","authors":"Silu Liu, Qingqing Pan, Hongzhe Zhang, Linyi Peng, Wen Zhang, YunLu Feng, Dong Wu, Yaping Luo","doi":"10.2967/jnumed.124.268943","DOIUrl":null,"url":null,"abstract":"<p>IgG4-related disease (IgG4-RD) is a highly heterogeneous autoimmune disease. Recently, 2 subtypes of IgG4-RD, proliferative and fibrotic, were defined according to patients’ clinicopathologic characteristics. The purpose of this study was to determine the difference in fibroinflammatory activity shown on <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT in the proliferative and fibrotic IgG4-RD subtypes. <strong>Methods:</strong> Thirty-seven newly diagnosed IgG4-RD patients (29 of the proliferative subtype and 8 of the fibrotic subtype) who had undergone <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT were enrolled. SUV<sub>max</sub> and target-to-background ratio (TBR) of IgG4-RD lesions were measured. To evaluate the weight of fibroinflammatory activity, the PET index of a lesion was calculated as the quotient of SUV<sub>max</sub> or TBR of <sup>68</sup>Ga-FAPI-04 and that of <sup>18</sup>F-FDG. For the assessment of the global disease in an individual patient, the PET index was defined as the ratio of SUV<sub>mean</sub> of all involved lesions in <sup>68</sup>Ga-FAPI-04 PET/CT to that in <sup>18</sup>F-FDG. <strong>Results:</strong> The <sup>18</sup>F-FDG uptake values of the most prominent lesions in the proliferative and fibrotic subtypes were similar; however, the proliferative subtype showed significantly higher uptake of <sup>68</sup>Ga-FAPI-04 than did the fibrotic subtype (SUV<sub>max</sub>, 17.67 ± 7.46 vs. 10.93 ± 2.22, <em>P</em> = 0.005; TBR, 15.49 ± 8.23 vs. 9.25 ± 3.00, <em>P</em> = 0.015). The PET index of proliferative-subtype patients was higher than that of fibrotic-subtype patients (1.46 ± 0.41 vs. 1.14 ± 0.39, <em>P</em> = 0.039). The PET index of pancreatobiliary disease was significantly higher than that of head-and-neck disease, fibrosis or aortitis, lymph nodes, and another disease subtype (<em>P</em> < 0.05). After first-line treatment, patients with a PET index of at least 1.5 had significantly shorter relapse-free survival than those with a PET index of less than 1.5 (22.0 mo vs. not reached, <em>P</em> < 0.0001; hazard ratio, 13.46; 95% CI, 2.236–81.03). <strong>Conclusion:</strong> The proliferative subtype of IgG4-RD had a greater weight of fibroinflammatory activity than that of the fibrotic subtype. The PET index, a marker of the weight of fibroinflammatory activity, is predictive of relapse-free survival of IgG4-RD.</p>","PeriodicalId":22820,"journal":{"name":"The Journal of Nuclear Medicine","volume":"318 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2967/jnumed.124.268943","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
IgG4-related disease (IgG4-RD) is a highly heterogeneous autoimmune disease. Recently, 2 subtypes of IgG4-RD, proliferative and fibrotic, were defined according to patients’ clinicopathologic characteristics. The purpose of this study was to determine the difference in fibroinflammatory activity shown on 68Ga-FAPI-04 and 18F-FDG PET/CT in the proliferative and fibrotic IgG4-RD subtypes. Methods: Thirty-seven newly diagnosed IgG4-RD patients (29 of the proliferative subtype and 8 of the fibrotic subtype) who had undergone 68Ga-FAPI-04 and 18F-FDG PET/CT were enrolled. SUVmax and target-to-background ratio (TBR) of IgG4-RD lesions were measured. To evaluate the weight of fibroinflammatory activity, the PET index of a lesion was calculated as the quotient of SUVmax or TBR of 68Ga-FAPI-04 and that of 18F-FDG. For the assessment of the global disease in an individual patient, the PET index was defined as the ratio of SUVmean of all involved lesions in 68Ga-FAPI-04 PET/CT to that in 18F-FDG. Results: The 18F-FDG uptake values of the most prominent lesions in the proliferative and fibrotic subtypes were similar; however, the proliferative subtype showed significantly higher uptake of 68Ga-FAPI-04 than did the fibrotic subtype (SUVmax, 17.67 ± 7.46 vs. 10.93 ± 2.22, P = 0.005; TBR, 15.49 ± 8.23 vs. 9.25 ± 3.00, P = 0.015). The PET index of proliferative-subtype patients was higher than that of fibrotic-subtype patients (1.46 ± 0.41 vs. 1.14 ± 0.39, P = 0.039). The PET index of pancreatobiliary disease was significantly higher than that of head-and-neck disease, fibrosis or aortitis, lymph nodes, and another disease subtype (P < 0.05). After first-line treatment, patients with a PET index of at least 1.5 had significantly shorter relapse-free survival than those with a PET index of less than 1.5 (22.0 mo vs. not reached, P < 0.0001; hazard ratio, 13.46; 95% CI, 2.236–81.03). Conclusion: The proliferative subtype of IgG4-RD had a greater weight of fibroinflammatory activity than that of the fibrotic subtype. The PET index, a marker of the weight of fibroinflammatory activity, is predictive of relapse-free survival of IgG4-RD.